Young developmental age cardiac extracellular matrix promotes the expansion of neonatal cardiomyocytes in vitro
Source abstract
Abstract
A major limitation to cardiac tissue engineering and regenerative medicine strategies is the lack of proliferation of postnatal cardiomyocytes. The extracellular matrix (ECM) is altered during heart development, and studies suggest that it plays an important role in regulating myocyte proliferation. Here, the effects of fetal, neonatal and adult cardiac ECM on the expansion of neonatal rat ventricular cells in vitro are studied. At 24h, overall cell attachment was lowest on fetal ECM; however, ~80% of the cells were cardiomyocytes, while many non-myocytes attached to older ECM and poly-l-lysine controls. After 5 days, the cardiomyocyte population remained highest on fetal ECM, with a 4-fold increase in number. Significantly more cardiomyocytes stained positively for the mitotic marker phospho-histone H3 on fetal ECM compared with other substrates at 5 days, suggesting that proliferation may be a major mechanism of cardiomyocyte expansion on young ECM. Further study of the beneficial properties of early developmental aged cardiac ECM could advance the design of novel biomaterials aimed at promoting cardiac regeneration.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Tissue Engineering and Regenerative Medicine · Electrospun Nanofibers in Biomedical Applications · Congenital heart defects research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (62)
Show source-provided references
1. Noninherited risk factors and congenital cardiovascular defects: current knowledge: a scientific statement from the American Heart Association council on cardiovascular disease in the young: endorsed by the American Academy of Pediatrics10.1161/CIRCULATIONAHA.106.183216 ↗
2. Hypoplastic left heart syndrome
3. The fontan procedure: anatomy, complications, and manifestations of failure10.1148/rg.312105027 ↗
4. Midterm clinical result of tissue-engineered vascular autografts seeded with autologous bone marrow cells10.1016/j.jtcvs.2004.12.047 ↗
5. Late-term results of tissue-engineered vascular grafts in humans10.1016/j.jtcvs.2009.09.057 ↗
6. Tissue-engineered cardiac constructs for cardiac repair10.1016/j.athoracsur.2010.09.080 ↗
7. Cardiac tissue engineering: implications for pediatric heart surgery10.1007/s00246-009-9405-6 ↗
8. Rapid transition of cardiac myocytes from hyperplasia to hypertropy during postnatal development10.1006/jmcc.1996.0163 ↗
9. Cardiomyocyte DNA synthesis and binucleation during murine development
10. Cardiomyocyte proliferation contributes to heart growth in young humans10.1073/pnas.1214608110 ↗
11. Survey of studies examining mammalian cardiomyocyte DNA synthesis10.1161/01.RES.83.1.15 ↗
12. Cellular cardiomyoplasty improves survival after myocardial injury10.1161/01.CIR.0000016063.66513.BB ↗
13. Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia10.1038/nature06321 ↗
14. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function10.1067/mtc.2000.104865 ↗
15. Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function10.1089/ten.tea.2010.0259 ↗
16. Compensatory growth of healthy cardiac cells in the presence of diseased cells restores tissue homeostasis during heart development10.1016/j.devcel.2008.09.005 ↗
17. Endothelial-cardiomyocyte interactions in cardiac development and repair10.1146/annurev.physiol.68.040104.124629 ↗
18. Cardiac fibroblasts regulate myocardial proliferation through beta1 integrin signaling10.1016/j.devcel.2008.12.007 ↗
19. Engineered early embryonic cardiac tissue increases cardiomyocyte proliferation by cyclic mechanical stretch via p38-MAP kinase phosphorylation10.1089/ten.tea.2008.0169 ↗
20. Three-dimensional myofiber architecture of the embryonic left ventricle during normal development and altered mechanical loads10.1002/ar.a.20133 ↗
21. Age-related changes in collagen synthesis and degradation in rat tissues10.1042/bj2760307 ↗
22. Fibronectin expression during physiological and pathological cardiac growth10.1016/0022-2828(95)90067-5 ↗
23. Expression of alpha and beta integrins during terminal differentiation of cardiomyocytes10.1016/S0008-6363(00)00140-1 ↗
24. Fibroblast growth factor-2 regulates proliferation of cardiac myocytes in normal and hypoplastic left ventricles in the developing chick10.1017/S1047951109003552 ↗
25. The extracellular matrix: at the center of it all10.1016/j.yjmcc.2009.08.024 ↗
26. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation10.1016/S0925-4773(01)00356-2 ↗
27. Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair10.1038/nm1619 ↗
28. Differential effect of myocardial matrix and integrins on cardiac differentiation of human mesenchymal stem cells10.1016/j.diff.2010.02.005 ↗
29. The extracellular matrix as a biologic scaffold material10.1016/j.biomaterials.2007.04.043 ↗
30. Naturally derived myocardial matrix as an injectable scaffold for cardiac tissue engineering10.1016/j.biomaterials.2009.06.045 ↗
31. Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering10.1089/ten.tea.2009.0768 ↗
32. Fabrication of cardiac patch with decellularized porcine myocardial scaffold and bone marrow mononuclear cells10.1002/jbm.a.32781 ↗
33. Perfusion-decellularized matrix: using nature’s platform to engineer a bioartificial heart10.1038/nm1684 ↗
34. The quest for an optimized protocol for whole heart decellularization: a comparison of three popular and a novel decellularization technique and their diverse effects on crucial extracellular matrix qualities10.1089/ten.tec.2011.0210 ↗
35. Tissue-engineered myocyardial patch derived from extracellular matrix provides regional mechanical function10.1161/CIRCULATIONAHA.104.524355 ↗
36. Renal tissue engineering with decellularized rhesus monkey kidneys: age-related differences10.1089/ten.tea.2010.0714 ↗
37. Decellularized rhesus monkey kidney as a three-dimensional scaffold for renal tissue engineering10.1089/ten.tea.2009.0602 ↗
38. Sample prep for proteomics of breast cancer: proteomics and gene ontology reveal dramatic differences in protein solubilization preferences of radioimmunoprecipitation assay and urea lysis buffers10.1186/1477-5956-6-30 ↗
39. Characterization of metabolic changes associated with the functional development of 3D engineered tissues by non-invasive, dynamic measurement of individual cell redox ratios10.1016/j.biomaterials.2012.04.024 ↗
40. Cell–cell interactions mediate the response of vascular smooth muscle cells to substrate stiffness10.1016/j.bpj.2011.06.051 ↗
41. Simple and high yielding method for preparing tissue specific extracellular matrix coatings for cell culture10.1371/journal.pone.0013039 ↗
42. Encapsulation of cardiomyocytes in a fibrin hydrogel for cardiac tissue engineering
43. P38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes10.1101/gad.1306705 ↗
44. Evidence for cardiomyocyte renewal in humans10.1126/science.1164680 ↗
45. Second harmonic generation microscopy for quantitative analysis of collagen fibrillar structure10.1038/nprot.2012.009 ↗
46. Decellularization of tissues and organs
47. Optimizing engineered heart tissue for therapeutic applications as surrogate heart muscle
48. Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repair10.1161/CIRCRESAHA.108.188649 ↗
49. Transient regenerative potential of the neonatal mouse heart10.1126/science.1200708 ↗
50. Characterization and functionality of cardiac progenitor cells in congenital heart patients10.1161/CIRCULATIONAHA.110.971622 ↗
51. Expression of type VI collagen in the developing mouse heart10.1002/(SICI)1097-0177(199803)211:3<248::AID-AJA6>3.0.CO;2-H ↗
52. Identification and detection of the periostin gene in cardiac development10.1002/ar.a.20135 ↗
53. Enhanced deposition of predominantly type I collagen in myocardial disease10.1016/0022-2828(90)90079-H ↗
54. Relative distribution and crosslinking of collagen distinguish fetal from adult sheep wound repair10.1016/S0022-3468(99)90261-0 ↗
55. Integrins in development: moving on, responding to, and sticking to the extracellular matrix10.1016/S1534-5807(02)00265-4 ↗
56. Cardiomyogenesis in the developing heart is regulated by c-kit-positive cardiac stem cells10.1161/CIRCRESAHA.111.259507 ↗
57. C-kit expression identifies cardiovascular precursors in the neonatal heart10.1073/pnas.0808920106 ↗
58. C-kit+ precursors support postinfarction myogenesis in the neonatal, but not adult, heart10.1073/pnas.1208114109 ↗
59. A strong regenerative ability of cardiac stem cells derived from neonatal hearts10.1161/CIRCULATIONAHA.111.084699 ↗
60. A naturally derived cardiac extracellular matrix enhances cardiac progenitor cell behavior in vitro10.1016/j.actbio.2012.07.033 ↗
61. Cardiac fibroblasts: at the heart of myocardial remodeling10.1016/j.pharmthera.2009.05.002 ↗
62. Intense myocyte formation from cardiac stem cells in human cardiac hypertrophy10.1073/pnas.1832855100 ↗